Financial Results For half year ended 30-09-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 4.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Patel Chem Specialities reported revenue from operations of ₹6,115.81 lakhs for H1 FY26 (April–September 2025), up about 22% from ₹5,013.93 lakhs in the same period last year. Total income rose to ₹6,164.51 lakhs vs ₹5,028.99 lakhs. Profit before tax grew to ₹800.72 lakhs (vs ₹698.92 lakhs) and profit after tax rose to ₹612.92 lakhs (vs ₹522.41 lakhs), a growth of roughly 17%. Basic EPS stood at ₹3.03, lower than ₹6.68 a year ago, mainly because the share count rose sharply after the company's recent IPO. The auditor (Parikh Shah & Associates) issued an unqualified limited review report with no qualifications or emphasis of matter. The balance sheet expanded nearly two-fold to ₹13,018.45 lakhs, with cash and bank balances jumping to ₹3,998.92 lakhs (from ₹64.07 lakhs) following the IPO. Debt-to-equity remains very low at 0.08. The company also separately disclosed related party transactions involving promoter group entities.
Strong top-line growth and steady profitability, supported by a clean audit report and a strong post-IPO cash position, are positive signals. Shareholders should note that EPS appears diluted due to the fresh equity issued in the IPO, which is a one-time effect rather than a decline in business performance.